Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · February 10, 2024

Perioperative Toripalimab Plus Chemotherapy for the Treatment of Patients With Resectable NSCLC

JAMA: The Journal of the American Medical Association


Additional Info

JAMA: The Journal of the American Medical Association
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non-Small Cell Lung Cancer: The Neotorch Randomized Clinical Trial
JAMA 2024 Jan 16;331(3)201-211, S Lu, W Zhang, L Wu, W Wang, P Zhang, , W Fang, W Xing, Q Chen, L Yang, J Mei, L Tan, X Sun, S Xu, X Hu, G Yu, D Yu, N Yang, Y Chen, J Shan, L Xing, H Tian, X Zhang, M Zhou, H Fang, G Wu, Y Liu, M Ye, L Cao, J Jiang, X Li, L Zhu, D Li, M Kang, A Zhong, K Chen, N Wu, Q Sun, H Ma, K Cai, C Wang, G Lin, K Zhu, Y Zhang, X Zhang, H Hu, W Zhang, J Chen, Z Yang, X Hang, J Hu, Y Huang, Z Zhang, L Zhang, L Zhang, L Liu, D Lin, J Zhang, G Chen, Y Li, L Zhu, W Wang, W Yu, D Cao, P Keegan, S Yao

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading